Development and validation of the competing risk nomogram and risk classification system for predicting cancer-specific mortality in patients with cervical adenosquamous carcinoma treated via radical hysterectomy. Biomol Biomed. 2025;25(5):1099–1110. doi:10.17305/bb.2024.11217